In a series of moves intended to beef up its pipeline, Pfizer Inc. appointed a new head of global research and development and launched an independent biotech research and development center in San Francisco.
In a series of moves intended to beef up its pipeline, Pfizer Inc. appointed a new head of global research and development and launched an independent biotech research and development center in San Francisco.
